秦哚昔芬(英語:Zindoxifene,开发名:D-16726、NSC-341952等),分子式C21H21NO4,是一种非甾体選擇性雌激素受體調節物(SERM),1980年代1990到早期为治疗乳腺癌而开发,从未上市[1]。
它可以1-乙基-5-甲氧基-2-(4-甲氧基苯基)-3-甲基吲哚为原料制得。[2]
Note: Though not listed here, many anabolic steroids can also be estrogenic as they can be aromatized into estrogen-like metabolites that possess estrogenic activity.
脚注: 不包括環境雌激素(例如植物雌激素和黴菌雌激素)。完整環境雌激素見此(英语:Template:Xenoestrogens)。
Note: 5α-reductase and 21-hydroxylase(英语:21-hydroxylase) inhibitors may also affect estrogen levels as they prevent metabolism of estrogen steroid precursors.